Aspire Biopharma Holdings, Inc.
ASBPW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847345
No open-market purchases or sales by Aspire Biopharma Holdings, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $145.4K in total; no superinvestor holds it.
Other share classesASBP
13F holders, Q1 2023
Institutional positions in Aspire Biopharma Holdings, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- 0 vs. Q4 2022
- Shares held
- 9.45M
- +180.0K (+1.9%) vs. Q4 2022
- Total value
- $399.0K
- −$200.8K (−33.5%) vs. Q4 2022
- New holders
- 1
- 3 more added
- Sold out
- 1
- 3 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ASBPW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $145.4K |
| Q1 2026 | 31 | $121.7K |
| Q4 2025 | 31 | $142.5K |
| Q3 2025 | 31 | $246.3K |
| Q2 2025 | 31 | $395.1K |
| Q1 2025 | 29 | $639.8K |
| Q4 2024 | 28 | $378.3K |
| Q3 2024 | 32 | $343.1K |
| Q2 2024 | 35 | $289.3K |
| Q1 2024 | 36 | $299.9K |
| Q4 2023 | 37 | $590.3K |
| Q3 2023 | 40 | $494.7K |
| Q2 2023 | 41 | $490.5K |
| Q1 2023 | 36 | $399.0K |
| Q4 2022 | 37 | $627.8K |
| Q3 2022 | 37 | $1.28M |
| Q2 2022 | 37 | $1.38M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Aspire Biopharma Holdings, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Investors Research Corp | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Athos Capital Ltd | 24,999 | $262 | 0.20% | 00.0% | Unchanged |
| Bulldog Investors, LLP | 12,500 | $523 | 0.00% | 00.0% | Unchanged |
| PEAK6 Investments LLC | 12,500 | $523 | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 25,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Omers Administration Corp | 25,000 | $1.04K | 0.00% | 00.0% | Unchanged |
| Atalaya Capital Management LP | 50,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Flow State Investments, L.P. | 55,000 | $2.30K | 0.00% | +4,951+9.9% | Added |
| Clear Street LLC | 56,084 | $2.34K | 0.00% | −97,194−63.4% | Reduced |
| Picton Mahoney Asset Management | 75,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Caas Capital Management LP | 75,000 | $3.13K | 0.00% | 00.0% | Unchanged |
| Difesa Capital Management, LP | 75,000 | $3.13K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | – | $4.00K | 0.00% | – | – |
| Kim, LLC | 100,000 | $4.18K | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 125,000 | $5.22K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 138,536 | $5.79K | 0.00% | 00.0% | Unchanged |
| Sage Rock Capital Management LP | 160,076 | $6.69K | 0.00% | 00.0% | Unchanged |
| Cohanzick Management, LLC | 166,667 | $6.97K | 0.01% | +166,667 | New |
| Context Capital Management, LLC | 175,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Radcliffe Capital Management, L.P. | 163,800 | $7.37K | 0.00% | 00.0% | Unchanged |
| Nomura Holdings Inc | 150,000 | $7.50K | 0.00% | 00.0% | Unchanged |
| Spartan Fund Management Inc. | 187,080 | $7.82K | 0.00% | +142,486+319.5% | Added |
| D. E. Shaw & Co., Inc. | 199,999 | $8.36K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 200,000 | $8.36K | 0.00% | 00.0% | Unchanged |
| Taconic Capital Advisors LP | 300,000 | $12.5K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 350,000 | $14.6K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 401,544 | $16.8K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 432,757 | $18.1K | 0.00% | 00.0% | Unchanged |
| Sculptor Capital LP | 500,000 | $22.5K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 651,245 | $27.2K | 0.00% | −18,753−2.8% | Reduced |
| Linden Advisors LP | 899,999 | $40.5K | 0.00% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,050,000 | $43.9K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 983,603 | $44.3K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 1,436,965 | $60.1K | 0.00% | +8,500+0.6% | Added |
| Mangrove Partners | 62,605 | – | – | −2,100−3.2% | Reduced |
| LMR Partners LLP | 125,000 | – | – | 00.0% | Unchanged |
| CVI Holdings, LLC | 0 | $0 | 0.00% | −24,600−100.0% | Sold out |
| Kepos Capital LP | – | – | – | – | Not filed |